{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:47:03Z","timestamp":1770284823982,"version":"3.49.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Our previous study reported that histamine H2 receptor antagonists (H2RAs) exposure was associated with decreased mortality in critically ill patients with heart failure (HF) through the same pharmacological mechanism as \u03b2-blockers. However, population-based clinical study directly comparing the efficacy of H2RAs and \u03b2-blockers on mortality of HF patients are still lacking. This study aims to compare the association difference of H2RAs and \u03b2-blockers on mortality in critically ill patients with HF using the Medical Information Mart for Intensive Care III database (MIMIC-III).<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Study population was divided into 4 groups: \u03b2-blockers + H2RAs group, \u03b2-blockers group, H2RAs group, and Non-\u03b2-blockers + Non-H2RAs group. Kaplan\u2013Meier curves and multivariable Cox regression models were employed to evaluate the differences of all-cause mortalities among the 4 groups. Propensity score matching (PSM) was used to increase comparability of four groups.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 5593 patients were included. After PSM, multivariate analyses showed that patients in H2RAs group had close all-cause mortality with patients in \u03b2-blockers group. Furthermore, 30-day, 1-year, 5-year and 10-year all-mortality of patients in \u03b2-blockers + H2RAs group were significantly lower than those of patients in \u03b2-blockers group, respectively (HR: 0.64, 95%CI: 0.50\u20130.82 for 30-day; HR: 0.80, 95%CI: 0.69\u20130.93 for 1-year mortality; HR: 0.83, 95%CI: 0.74\u20130.93 for 5-year mortality; and HR: 0.85, 95%CI: 0.76\u20130.94 for 10-year mortality, respectively).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> H2RAs exposure exhibited comparable all-cause mortality-decreasing effect as \u03b2-blockers; and, furthermore, H2RAs and \u03b2-blockers had additive or synergistic interactions to improve survival in critically ill patients with HF.<\/jats:p>","DOI":"10.3389\/fphar.2023.1273640","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T02:13:15Z","timestamp":1699927995000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Histamine H2 receptor antagonist exhibited comparable all-cause mortality-decreasing effect as \u03b2-blockers in critically ill patients with heart failure: a cohort study"],"prefix":"10.3389","volume":"14","author":[{"given":"Xue-Sha","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Ke","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Jun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang-Fang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Mei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gong-Hao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2147\/CLEP.S162909","article-title":"Use of histamine H2 receptor antagonists and outcomes in patients with heart failure: a nationwide population-based cohort study","volume":"10","author":"Adelborg","year":"2018","journal-title":"Clin. Epidemiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/opo.12131","article-title":"When to use the Bonferroni correction","volume":"34","author":"Armstrong","year":"2014","journal-title":"Ophthalmic Physiol. Opt."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1111\/bcp.15330","article-title":"Psoriasis risk after beta-blocker exposure: description of a pharmacovigilance signal","volume":"88","author":"Azzouz","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1001\/jama.2020.13310","article-title":"Heart failure","volume":"324","author":"Baman","year":"2020","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.amjmed.2020.07.023","article-title":"Complex and potentially harmful medication patterns in heart failure with preserved ejection fraction","volume":"134","author":"Brinker","year":"2021","journal-title":"Am. J. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0002-9149(82)90298-3","article-title":"Histamine and the human heart: the other receptor system","volume":"49","author":"Bristow","year":"1982","journal-title":"Am. J. Cardiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/eurheartj\/ehx564","article-title":"Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials","volume":"39","author":"Cleland","year":"2018","journal-title":"Eur. Heart J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"G987","DOI":"10.1152\/ajpgi.1997.273.5.G987","article-title":"Novel insights into histamine H2 receptor biology","volume":"273","author":"Del Valle","year":"1997","journal-title":"Am. J. Physiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ahj.2018.06.017","article-title":"Loop diuretic adjustments in patients with chronic heart failure: insights from HF-ACTION","volume":"205","author":"Fudim","year":"2018","journal-title":"Am. Heart J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1177\/02698811211034810","article-title":"\u03b2-adrenoceptor antagonists and nightmares: a pharmacoepidemiological\u2013pharmacodynamic study","volume":"35","author":"Garcia","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1084\/jem.20002036","article-title":"Evidence for a role of mast cells in the evolution to congestive heart failure","volume":"195","author":"Hara","year":"2002","journal-title":"J. Exp. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2119\/molmed.2011.00225","article-title":"Arrhythmogenic effect of sympathetic histamine in mouse hearts subjected to acute ischemia","volume":"18","author":"He","year":"2012","journal-title":"Mol. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1111\/j.1471-4159.2008.05532.x","article-title":"Sympathetic histamine exerts different pre- and post-synaptic functions according to the frequencies of nerve stimulation in Guinea pig vas deferens","volume":"106","author":"He","year":"2008","journal-title":"J. Neurochem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.neuropharm.2009.07.029","article-title":"Alpha2 adrenoceptors modulate histamine release from sympathetic nerves in the Guinea pig vas deferens","volume":"57","author":"He","year":"2009","journal-title":"Neuropharmacology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e876","DOI":"10.1161\/CIR.0000000000001062","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/WNR.0b013e328345216a","article-title":"Exocytosis and mobility of histamine vesicles exhibit no difference to that of histamine-negative vesicles in Guinea pig superior cervical ganglion neurons","volume":"22","author":"Hu","year":"2011","journal-title":"Neuroreport"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1093\/eurjpc\/zwac122","article-title":"Histamine H2 receptor antagonist exposure was related to decreased all-cause mortality in critical ill patients with heart failure: a cohort study","volume":"29","author":"Huang","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"160035","DOI":"10.1038\/sdata.2016.35","article-title":"MIMIC-III, a freely accessible critical care database","volume":"3","author":"Johnson","year":"2016","journal-title":"Sci. Data"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","article-title":"Efficacy of \u03b2 blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis","volume":"384","author":"Kotecha","year":"2014","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.3390\/ijms19071999","article-title":"Involvement of allosteric effect and KCa channels in crosstalk between \u03b2\u2082-adrenergic and muscarinic M\u2082 receptors in airway Smooth Muscle","volume":"19","author":"Kume","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"k3532","DOI":"10.1136\/bmj.k3532","article-title":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)","volume":"363","author":"Langan","year":"2018","journal-title":"BMJ"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e024270","DOI":"10.1161\/JAHA.121.024270","article-title":"Histamine H2 receptor antagonists and heart failure risk in postmenopausal women: the women's health initiative","volume":"11","author":"Larson","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1513\/AnnalsATS.201407-344OC","article-title":"H2 receptor antagonists and right ventricular morphology: the MESA right ventricle study","volume":"11","author":"Leary","year":"2014","journal-title":"Ann. Am. Thorac. Soc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/j.jacc.2016.01.045","article-title":"Histamine H2 receptor antagonists, left ventricular morphology, and heart failure risk: the MESA study","volume":"67","author":"Leary","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/jcph.2147","article-title":"Effectiveness and safety of histamine H2 receptor antagonists: an umbrella review of meta-analyses","volume":"63","author":"Meng","year":"2023","journal-title":"J. Clin. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e006213","DOI":"10.1161\/CIRCHEARTFAILURE.119.006213","article-title":"Heart rate and heart failure with preserved ejection fraction: time to slow \u03b2-blocker use?","volume":"12","author":"Meyer","year":"2019","journal-title":"Circ. Heart Fail"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s41440-018-0109-2","article-title":"Association of histamine with hypertension-induced cardiac remodeling and reduction of hypertrophy with the histamine-2-receptor antagonist famotidine compared with the beta-blocker metoprolol","volume":"41","author":"Potnuri","year":"2018","journal-title":"Hypertens. Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13054-022-04016-x","article-title":"Effect of erythromycin on mortality and the host response in critically ill patients with sepsis: a target trial emulation","volume":"26","author":"Reijnders","year":"2022","journal-title":"Crit. Care"},{"key":"B29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13058-022-01526-y","article-title":"Beta 2 adrenergic receptor and mu opioid receptor interact to potentiate the aggressiveness of human breast cancer cell by activating the glycogen synthase kinase 3 signaling","volume":"24","author":"Rousseau","year":"2022","journal-title":"Breast Cancer Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.drudis.2021.08.008","article-title":"Histamine 2 receptors in cardiovascular biology: a friend for the heart","volume":"27","author":"Saheera","year":"2022","journal-title":"Drug Discov. Today"},{"key":"B31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/MAJ.0b013e3182249fcd","article-title":"Oxidative stress in heart failure: what are we missing?","volume":"342","author":"Sawyer","year":"2011","journal-title":"Am. J. Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ejphar.2004.07.055","article-title":"Mechanisms underlying postjunctional synergism between responses of the vas deferens to noradrenaline and ATP","volume":"498","author":"Smith","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00395-010-0119-y","article-title":"A histamine H\u2082 receptor blocker ameliorates development of heart failure in dogs independently of \u03b2-adrenergic receptor blockade","volume":"105","author":"Takahama","year":"2010","journal-title":"Basic Res. Cardiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00002512-200016010-00001","article-title":"Beta-blockers for congestive heart failure: what is the current consensus?","volume":"16","author":"Tsuyuki","year":"2000","journal-title":"Drugs Aging"},{"key":"B35","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3390\/antiox8110512","article-title":"Gastro-protective and anti-oxidant potential of althaea officinalis and Solanum nigrum on pyloric ligation\/indomethacin-induced ulceration in rats","volume":"8","author":"Zaghlool","year":"2019","journal-title":"Antioxidants (Basel)."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0409","DOI":"10.1097\/MD.0000000000010409","article-title":"Cardioprotective effect of histamine H2 antagonists in congestive heart failure: a systematic review and meta-analysis","volume":"97","author":"Zhang","year":"2018","journal-title":"Med. Baltim."},{"key":"B37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.21037\/atm.2016.08.57","article-title":"Propensity score method: a non-parametric technique to reduce model dependence","volume":"5","author":"Zhang","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.21037\/atm.2018.12.10","article-title":"Balance diagnostics after propensity score matching","volume":"7","author":"Zhang","year":"2019","journal-title":"Ann. Transl. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1273640\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T02:13:17Z","timestamp":1699927997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1273640\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":38,"alternative-id":["10.3389\/fphar.2023.1273640"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1273640","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,13]]},"article-number":"1273640"}}